Benefits of a universal influenza immunization program: More than the reduction in the use of antibiotics

Clinical Infectious Diseases

Volumn 49, Issue 5, 2009, Pages 757-758

  Glezen, W Paul ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LIVE VACCINE; VIRUS VACCINE;

EMERGENCY WARD; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INFLUENZA; MEDICAL EDUCATION; MORTALITY; NOTE; NURSE; PHYSICIAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; VACCINATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS IMMUNIZATION; ONTARIO; PUBLIC HEALTH; UNITED STATES; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 70149101830     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605088     Document Type: Note

References (12)

1. Kwong JC, Maaten S, Upshur REG, Patrick DM, Marra F. The effect of universal immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis 2009; 49: 750-756 (in this issue).
2. Kwong JC, Rosella LC, Johansen H. Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Rep 2007; 18:9-19.
3. Centers for Disease Control and Prevention. State-specific influenza vaccination coverage among adults aged ≥18 years-United States, 2003-2004 and 2005-06 influenza seasons. MMWR Morb Mortal Wkly Rep 2007; 56: 953-959
4. Kwong JC, Stukel TA, Lim J, et al. The effect of universal immunization on mortality and health care use. PLoS Med 2008;5:e211.
5. Glezen WP. Herd protection against influenza. J Clin Virol 2006; 37:237-243
6. King JC Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006; 355:2523-2532
7. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenzarelated illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23:1540-1548
8. Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2005; 134:71-78
9. Glezen WP. Universal influenza vaccination and live attenuated influenza vaccination of children. Pediatr Infect Dis J 2008; 27:S104-9.
10. Piedra PA, Gaglani MJ, Riggs M, et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open label trial. Pediatrics 2005;116:e397-407. (Pubitemid 44339432)
11. Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr Infect. Dis J 2008; 27:444-452
12. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Trivalent live attenuated influenza vaccine administered during the 2003-2004 influenza type A(H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007; 120:e553-64.